1. Home
  2. SY vs CNTX Comparison

SY vs CNTX Comparison

Compare SY & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo So-Young International Inc. American Depository Shares

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$1.93

Market Cap

272.8M

Sector

Technology

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

283.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
CNTX
Founded
2013
2015
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.8M
283.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
SY
CNTX
Price
$1.93
$1.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$5.50
$6.60
AVG Volume (30 Days)
860.8K
626.5K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
0.91%
N/A
EPS Growth
N/A
17.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$38.64
N/A
Revenue Next Year
$30.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$0.56
52 Week High
$6.28
$3.62

Technical Indicators

Market Signals
Indicator
SY
CNTX
Relative Strength Index (RSI) 29.52 32.45
Support Level $1.86 $0.95
Resistance Level $3.34 $2.00
Average True Range (ATR) 0.21 0.22
MACD -0.05 -0.07
Stochastic Oscillator 5.88 0.36

Price Performance

Historical Comparison
SY
CNTX

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: